Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 7.45p
   
  • Change Today:
      0.000p
  • 52 Week High: 7.70p
  • 52 Week Low: 3.88p
  • Currency: UK Pounds
  • Shares Issued: 4,766.44m
  • Volume: 0
  • Market Cap: £355.10m
  • RiskGrade: 268

Latest ShareCast News

Allergy Therapeutics starts dosing peanut allergy vaccine candidate

By Josh White

Date: Monday 27 Mar 2023

(Sharecast News) - Allergy Therapeutics, a UK-based biotechnology company specialising in allergy vaccines, announced the start of the first application of its 'VLP Peanut' vaccine candidate in peanut-allergic patients on Monday.

AGY ShareCast News

Allergy Therapeutics confident in funding as res... 20-Jan-2023 ShareCast
Allergy Therapeutics pauses production at Freema... 04-Oct-2022 ShareCast
Allegy Therapeutics trades 'robustly' in tough y... 15-Jul-2022 ShareCast
Allergy Therapeutics reports positive results fr... 25-Oct-2021 ShareCast
Allergy Therapeutics upbeat on ex-vivo study of ... 03-Aug-2021 ShareCast

AGY Regulatory News

Interim Results for six months ended 31 Dec 2024 31-Mar-2025 07:00 RNS
Advancement to final phase of PROTECT trial 27-Mar-2025 07:00 RNS
New Executive Long Term Incentive Awards 03-Mar-2025 07:00 RNS
Grass MATA MPL Phase III data published in Allergy 17-Feb-2025 07:00 RNS
Grant of Options 14-Feb-2025 07:00 RNS

AGY Newspaper Links

Allergy drug firm hit by trials setback 12-Jul-2007 The Independent
Need to Know: Global Business Briefing 25-Mar-2006 Times

AGY Tips & Analysis

FTSE Close: BP and Lloyds lead rally 21-Sep-2010 Daily Mail
Tempus:Allergy Therapeutics 22-Sep-2009 Times
Investment Column:Allergy Therapeutics 22-Sep-2009 The Independent
Market report: Wednesday lastest 14-May-2008 Daily Mail
Market Report: Prudential gains after bid specul... 13-Mar-2008 The Independent

AGY News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 7.45p
Change Today 0.000p
% Change 0.00 %
52 Week High 7.70p
52 Week Low 3.88p
Volume 0
Shares Issued 4,766.44m
Market Cap £355.10m
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.98% below the market average68.98% below the market average68.98% below the market average68.98% below the market average68.98% below the market average
44.68% below the sector average44.68% below the sector average44.68% below the sector average44.68% below the sector average44.68% below the sector average
Price Trend
88.09% above the market average88.09% above the market average88.09% above the market average88.09% above the market average88.09% above the market average
95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average
Income Not Available
Growth
53.63% below the market average53.63% below the market average53.63% below the market average53.63% below the market average53.63% below the market average
67.74% below the sector average67.74% below the sector average67.74% below the sector average67.74% below the sector average67.74% below the sector average

AGY Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

AGY Key Personnel

CEO Manuel Llobet

Top of Page